CSS LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $378K | Buy |
720
+40
| +6% | +$21K | 0.02% | 470 |
|
2025
Q1 | $431K | Buy |
680
+70
| +11% | +$44.4K | 0.02% | 401 |
|
2024
Q4 | $435K | Buy |
+610
| New | +$435K | 0.02% | 407 |
|
2023
Q2 | – | Sell |
-300
| Closed | -$247K | – | 707 |
|
2023
Q1 | $247K | Sell |
300
-200
| -40% | -$164K | 0.02% | 403 |
|
2022
Q4 | $361K | Sell |
500
-100
| -17% | -$72.1K | 0.02% | 376 |
|
2022
Q3 | $413K | Hold |
600
| – | – | 0.02% | 430 |
|
2022
Q2 | $355K | Hold |
600
| – | – | 0.01% | 533 |
|
2022
Q1 | $419K | Sell |
600
-200
| -25% | -$140K | 0.02% | 524 |
|
2021
Q4 | $505K | Buy |
+800
| New | +$505K | 0.02% | 531 |
|
2020
Q4 | – | Sell |
-564
| Closed | -$316K | – | 681 |
|
2020
Q3 | $316K | Sell |
564
-335
| -37% | -$188K | 0.01% | 302 |
|
2020
Q2 | $561K | Buy |
+899
| New | +$561K | 0.03% | 222 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 525 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 521 |
|
2014
Q1 | – | Sell |
-10,254
| Closed | -$2.82M | – | 547 |
|
2013
Q4 | $2.82M | Buy |
+10,254
| New | +$2.82M | 0.14% | 104 |
|